Monday 12 January 2015

Shire to buy NPS for $5.2 billion to boost rare disease drugs

A sign sits in front of Shire's manufacturing facility in Lexington, Massachusetts LONDON (Reuters) - Shire Plc has agreed to buy U.S. group NPS Pharmaceuticals Inc for $5.2 billion, the Dublin-based drugmaker's biggest acquisition yet as it seeks to strengthen its position in the lucrative field of medicines for rare diseases.




via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment